WAM
TTPH

Wealthspire Advisors (Maryland)’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50
Closed -$1K – 2402
2019
Q1 		$1K Buy
+50
New +$1.27K ﹤0.01% 2445
2017
Q1 		– Sell
-10
Closed -$1K – 2062
2016
Q4 		$1K Hold
10
– – ﹤0.01% 1710
2016
Q3 		$1K Hold
10
– – ﹤0.01% 1685
2016
Q2 		$1K Hold
10
– – ﹤0.01% 1653
2016
Q1 		$1K Hold
10
– – ﹤0.01% 1701
2015
Q4 		$2K Buy
+10
New +$2K ﹤0.01% 1555

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s TTPH Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 50 shares — an estimated $1K sold.

Wealthspire Advisors (Maryland) first reported a position in TTPH in Q4 2015 and held it in 6 quarters. The position peaked at $2K in Q4 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 50 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1K.
  • Wealthspire Advisors (Maryland) first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2015 and held it in 6 quarters.
  • Wealthspire Advisors (Maryland)'s Tetraphase Pharmaceuticals, Inc. position peaked at $2K in Q4 2015.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.